Trials / Completed
CompletedNCT02864446
Intestinal Fatty Acid Binding Protein in Very Low Birth Weight Infants With Meconium Obstruction
The Clinical Utility of Urine Intestinal Fatty Acid Binding Protein in the Management of Very Low Birth Weight Infants With Meconium Obstruction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 36 Weeks
- Healthy volunteers
- Not accepted
Summary
Urinary intestinal fatty acid binding protein (i-FABP), a marker of intestinal mucosal cell damage, has recently been proposed as a clinically useful measure in the early detection of necrotizing enterocolitis (NEC). However, there are no data on urinary i-FABP in meconium obstruction of prematurity (MOP). This study aimed to evaluate urinary i-FABP in MOP patient as a marker for early detection.
Conditions
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2016-08-12
- Last updated
- 2016-08-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02864446. Inclusion in this directory is not an endorsement.